Arvest Investments’s Boston Scientific BSX Stock Holding History

Arvest Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135K	Sell	3,159 -3,177	-50%	-$173K	0.02%	174
2026 Q1	$398K	Buy	6,336 +3,353	+112%	+$268K	0.05%	148
2025 Q4	$284K	Sell	2,983 -10,008	-77%	-$981K	0.04%	153
2025 Q3	$1.27M	Sell	12,991 -149	-1%	-$15.4K	0.18%	98
2025 Q2	$1.41M	Buy	13,140 +203	+2%	+$20.5K	0.21%	92
2025 Q1	$1.31M	Buy	+12,937	New	+$1.3M	0.21%	102

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Arvest Investments's BSX Position: Q2 2026 in Review

Arvest Investments reduced its Boston Scientific (BSX) stake by 50% in Q2 2026, selling an estimated $173K and leaving 3,159 shares worth $135K. The position accounts for 0.02% of the portfolio, ranked #174.

Arvest Investments first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.41M in Q2 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Arvest Investments held 3,159 shares of Boston Scientific worth $135K as of Q2 2026.
Arvest Investments sold 3,177 Boston Scientific shares in Q2 2026, an estimated $173K.
Boston Scientific made up 0.02% of Arvest Investments's portfolio in Q2 2026, its #174 holding.
Arvest Investments first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
Arvest Investments's Boston Scientific position peaked at $1.41M in Q2 2025.
534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Arvest Investments's 13F filing for Q2 2026, filed 17 Jul 2026.